Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

About the Cover

Cover Figure


Immunofluorescence staining of NIH3T3 cells treated with DMSO (control, left column) or diallyl disulfide (56 μmol/L, right column), a garlic-derived organosulfur compound. In interphase cells, treatment with diallyl disulfide induces micronuclei formation (right column, upper panel) and microtubule stabilization (right column, middle panel). In mitotic cells, treatment with diallyl disulfide interferes with spindle-MT functions and induces the formation of lagging chromosomes (right column, lower panel). Chromosomal DNA is stained blue; microtubules, green; and stabilized microtubules, red. For details, see Xiao et al. in this issue.



[Table of Contents]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.